Company profile: Evidera
1.1 - Company Overview
Company description
- Provider of health economics, outcomes research, market access, data analytics, and epidemiology services for life sciences organizations worldwide, offering real-world evidence and data solutions; non-interventional and interventional studies; patient-centered research; evidence synthesis, modeling and communication; and strategic development consulting to support product value demonstration and market access.
Products and services
- Strategic Development Consulting: Delivers custom-engineered regulatory, clinical, and evidence-generation strategies spanning discovery through post-approval, architected to optimize market access and commercial success amid global payer and regulator landscapes
- Real-World Evidence & Data Solutions: Produces data-science-driven systems to generate and analyze real-world data supporting market access and product uptake, including database study designs, hybrid study designs, trial augmentation, and data science applications
- Evidence Synthesis, Modeling & Communication: Offers regulatory-grade HEOR assemblies combining evidence synthesis, modeling and simulation, and market access communications to demonstrate product value with robust, decision-ready insights for payers and regulators
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Evidera
Meridien Research
HQ: United States
Website
- Description: Provider of opportunities for patients and families to participate in clinical research trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Meridien Research company profile →
PPD
HQ: United States
Website
- Description: Provider of CRO services across multiple therapeutic areas, enabling accelerated innovation and drug development through patient-centered strategies and data analytics. Offerings include GMP laboratory and analytical services, Decentralized Clinical Trials, Accelerated Enrollment Solutions, Preclarus data integration tools, regulatory affairs services, and integrated clinical development consulting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PPD company profile →
Biosynth
HQ: Switzerland
Website
- Description: Provider of critical raw materials and services to the pharmaceutical and diagnostics industries, offering custom synthesis and manufacturing services. Focused on consolidating the fragmented supply chain to improve availability and reduce time-to-market for new therapies and diagnostic assays, increasing industry productivity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biosynth company profile →
OcellO
HQ: The Netherlands
Website
- Description: Provider of CRO services for the drug discovery industry, developing clinically relevant in vitro human micro-tissue models for screening and profiling of small molecules and biologics to improve the efficiency of lead development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OcellO company profile →
ApiJect
HQ: United States
Website
- Description: Provider of a medical technology platform enabling scalable manufacturing and fill-finish of prefilled, single-dose injectors using Blow-Fill-Seal aseptic packaging. Offers the Prefilled ApiJect Injector with a pen needle–style hub; technology licensing for BFS mold/device design, development and production support; and design and engineering services for BFS fill-finish of temperature-sensitive biologics and vaccines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ApiJect company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Evidera
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Evidera
2.2 - Growth funds investing in similar companies to Evidera
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Evidera
4.2 - Public trading comparable groups for Evidera
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →